Tech Company Financing Transactions
Bioliberty Funding Round
On 3/18/2026, Bioliberty raised $10.2 million in Series A funding from Archangels, Conduit EIS Impact Fund and Eos Advisory.
Transaction Overview
Company Name
Announced On
3/18/2026
Transaction Type
Venture Equity
Amount
$10,200,000
Round
Series A
Investors
Proceeds Purpose
The funds will enable the company to continue the development and U.S. commercialization of its transformative Lifehub Clinic platform, which will incorporate new computer vision and care coordination capabilities.
Company Information
Company Status
Private & Independent
Industry
Robotics
Mailing Address
Higgs Centre For Innovation Royal Observatory Edinburgh Blac
Edinburgh, Scotland, EH9 3HJ
UK
Edinburgh, Scotland, EH9 3HJ
UK
Phone
Undisclosed
Website
Email Address
Overview
Bioliberty's aim is to empower every human to live a longer independent life by providing assistive robotics and rehabilitative technologies. Four young engineers came together during a global pandemic to empower people living in social isolation. Witnessing the struggles of living with reduced mobility inspired their ideas. Their passion and focus was to enable people to live their lives independently.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rowan Armstrong
Browse more venture capital transactions:
Prev: 3/18/2026: Foresight venture capital transaction
Next: 3/19/2026: Eclypsium venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs